Figure 1

Patient selection for the study. EBRT = external-beam radiotherapy; NCCN = U.S. National Comprehensive Cancer Network guidelines (2019, version 4); NHT = neoadjuvant hormonal therapy; PSA = prostate-specific antigen; SEED-BT = seed brachytherapy.